Starting with mRNA derived from Staphylococcal enterotoxin A induced human splenocytes, dsDNA-was synthesized and inserted into the unique BamHI site of the eukaryotic expression vector pSV529 (1). A recombinant pITsmid containing human immune interferon (IFN-Y) cDNA was identified by hybridization of plasmid inserted DNA bound onto nitrocellulose filters with mRNA derived from SEA-induced splenocytes, translation of the eluted RNA in Xenopus laevis oocytes and assaying for IFN activity. Plasmids containing the entire human IFN-Y cONA sequence were identified by colony hybridization and were sequenced. A unique coding region was identified which predicted a protein of 166 amino acids, the 20 N-terminal amino acids of which presumably represent a signal peptide. After transfection of monkey cells with plasmid DNA isolated from one of the recombinant clones (pHIIF-SV-*8l), IFN was excreted into the culture medium. This IFN was not distinguishable from human IFN41 by serological criteria or by cell target species specificity.
INTRODUCTION
Immune interferon (IFN-Y) can be induced in lymphocytes by mitogens (2) , alloantigens (3) and other substances (4) (5) (6) (7) as well as being induced in sensitized lymphocytes by specific antigens (8) . Its production is dependent upon the presence either of macrophages or the macrophage product interleukin 1 (ILl) and this production is regulated by T-lymphocyte derived interleukin 2 (IL2) (9) . Biologically, immune interferon is a very interesting lymphokine with important immunoregulatory properties (10) . Reduced IFN4Y production seems to occur in certain immunodeficiencies (11) and IFN-1 has been found in the circulation of patients suffering from autoimmune diseases (12) . It has been shown that IFN-has a more potent anticellular activity (13, 14) and can activate natural killer cells to a higher extent (15) than other human IFNs. The antiviral effect (16) and the antitumour effect (17) of virus-induced IFNs (IFN-G and IFN-L ) can be potentiated by selected for their resistance towards fibroblast IFN (18) and the differential antiviral activity of IFN-L (19) points towards a different mechanism of action. Further important functional differences between the type I IFNs (IFN-.Cs, IFN-,S) and type II IFN (IFN-Y) include their different affinities for gangliosides (20) and their different membrane receptors (21) .
IFN-LV is produced by stimulated lymphocytes in minute quantities together with numerous other lymphokines. Only recently has extensive purification of IFN-t been achieved (22) and this has allowed a more precise determination of the molecular size (23) . The mRNA for IFN-'T isolated from human peripheral blood lymphocyte (PBL) cultures has been partially enriched and translated in Xenopus laevis oocytes (24) (25) (26) (27) .
Recently, we reported the characterization of IFN-r mRNA derived from SEA-induced human splenocytes (28) . We chose to use human spleen for the isolation of IFN-V mRNA because it is a source of appreciable and reproducible amounts of this mRNA, needed for the synthesis and identification of a cloned cDNA copy. In this report we describe the construction and identification of recombinant plasmids containing human IFN-V cDNA sequences, and the synthesis of human IFN-b by cultured monkey cells after transfection with the recombinant DNA in which the human IFN-T cDNA is under the control of SV40 late transcription. The results of similar work, i.e. on cloning, characterization and expression of IFN-Y cDNA derived from human PBLs have recently been published by Gray et al. (29) .
MATERIALS AND METHODS

Construction of cDNA plasmids
Poly eRNA was prepared from SEA-induced splenocyte cultures, purified by sucrose gradient centrifugation, and the IFN-G mRNA was identified by injecting aliquots into Xenopus laevis oocytes and after incubation for 72 hr assaying the incubation medium for IFN activity as described (28) . The peak of IFN-Y mRNA activity sedimented at around 13 S. cDNA was synthesized on 40 _g poly AtRNA (from a single donor, spleen 7; ref 28) using oligo(dT),%,& (P-L Biochemicals) as a primer, followed by second strand synthesis, SI-treatment and sizing on a 4% polyacrylamide gel essentially as described (30) . Molecules of dsDNA ranging in length between 800 and 1000 bp (g4), 1000 and 1250 bp (g3) and 1250 and 1400 bp (g2) were eluted from the gel, purified on hydroxyapatite and tailed with oligo dC. pSV529 DNA was used a a vector; it contains 1. 4 (32) , except that the RNA was eluted in the presence of 4yg poly A RNA (oligo(dT) cellulose runthrough RNA), and immediately precipitated without phenolization.
After centrifugation, the eluted mRNA was taken up in 2jd sterile HI0, injected (in duplo) into each of 15-20 Xenopus laevis oocytes, and after three days at 23 C the medium was assayed for IFN activity. Colony hybridization was as described (33, 34 (36) as described by Gheysen and Fiers (1) . After 24 hr and 72 hr, aliquots of the incubation medium were withdrawn and stored at -70°C until they were assayed for IFN activity. Assay and neutralization of IFN activity were performed as previously described (1, 28, 37 activity (data not shown). We concluded that either the IFN4' was expressed at a level below the detection limit of our assay, or that there was no clone present in the cDNA library which contained a complete IFN-Y cDNA copy inserted in the same orientation relative to transcription (see below).
Although the mRNA from which the recombinant plasmids were obtained was only purified 10-30 times after a single sucrose gradient step, relatively high titers of IFN4 were obtained after injection into Xenopus laevis oocytes (28) . Furthermore, since we had found the human spleen to be a reliable source of appreciable amounts of IFN4Y mRNA (28), we believed that a positive screening of the clones by cDNA-mRNA hybridization followed by translation in oocytes (32, 37) could be successful. Such a screening method could be rendered more sensitive by binding only "insert DNA" onto nitrocellulose filters, instead of binding total recombinant plasmid DNA. Since the BamHI site of the vector pSV529 was restored by the procedure used, "insert DNA" could be prepared by BamHI digestion of DNA from mixtures of 50 individual clones. This DNA was purified by sucrose gradient centrifugation (Fig. 1 (35) . The initiation and termination codons are shown in full outlined boxes. The AATAAA sequence near the polyadenylation signal is shown in a dashed box. The coding region is indicated by a heavy line above the nucleotide sequence; the vertical arrow indicates the position where the presumed signal peptide is cleaved. (23) and by Chen et al. (45) . The amino acid sequence shows a remarkably high content of basic residues which would explain the high pI value observed by Yip et al. (22) . More particularly, there are two clusters of four consecutive basic residues, viz. Lys-Lys-Lys-Arg (at position 89-92) and Lys-Arg-Lys-Arg (at position 131-134). The basic nature of the mature protein may be related to the acid lability of its biological activity. Since the only cysteine residues in the amino acid sequence occur at the NHI-terminal end (positions 1 and 3), it is unlikely that disulphide bridges are essential for maintaining the conformation of the mature protein. This is in agreement with the finding that the antiviral activity is retained after treatment with/p-mercaptoethanol (22, 23, 45, 49) and with the observation that there is sulfhydryl specific binding of human IFN4Y on an Affigel 501 matrix (50) . (Table 3 ). The antiviral activity was acid labile (Table 2) , and showed no virus protection on bovine, murine or feline cells (not shown). However, the antiviral activity of IFN-/3, produced after transfection of AP8 cells under similar conditions with an IFN-f cONA containing plasmid (pSV529-HFIF) was about 100 times higher. Clearly, this high level of expression is necessary for detection of an IFN cDNA containing clone in a mixture of randomly cloned cONA. The low level of expression of IFN- in AP8 cells transfected with pHIIF-SV-1l DNA could explain our inability to detect this clone using our direct screening method (see above). The reason for the difference in expression level between IFN-' and IFN-f3 containing chimaeras is not clear at present and needs further study.
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